Literature DB >> 17445160

Clinical importance of HLA-DPB1 in haematopoietic cell transplantation.

B E Shaw1, T Gooley, J A Madrigal, M Malkki, S G E Marsh, E W Petersdorf.   

Abstract

There is increasing evidence for a significant effect of human leukocyte antigen (HLA)-DPB1 mismatching on complications following unrelated donor haematopoietic cell transplantation (HCT). In this analysis of 5930 patient/donor pairs, we found that a DPB1 mismatch predicted significantly for an increased risk of acute graft-vs-host disease [hazard ratio (HR): 1.33; P-value = <0.0001], while protecting against disease relapse (HR: 0.82, P-value = 0.01). These data support an immunogenic role for HLA-DPB1 in HCT and the need for pretransplant tissue typing at this locus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17445160     DOI: 10.1111/j.1399-0039.2006.759_4.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  3 in total

1.  Is there any impact of HLA-DPB1 disparity in 10/10 HLA-matched unrelated hematopoietic SCT? Results of a French multicentric retrospective study.

Authors:  K Gagne; P Loiseau; V Dubois; F Dufossé; P Perrier; A Dormoy; I Jollet; V Renac; D Masson; C Picard; X Lafarge; D Hanau; F Quainon; F Delbos; B Coeffic; Léna Absi; J-F Eliaou; V Moalic; M Fort; M de Matteis; I Theodorou; F Hau; A Batho; B Pedron; S Caillat-Zucman; E Marry; N Raus; I Yakoub-Agha; A Cesbron
Journal:  Bone Marrow Transplant       Date:  2014-11-03       Impact factor: 5.483

2.  In a 12-allele analysis HLA-DPB1 matching is associated with improved OS in leukaemic and myelodysplastic patients receiving myeloablative T-cell-depleted PBSCT from unrelated donors.

Authors:  C Burt; A Parker; G McQuaker; M Copland; C Brierley; A-M Little; A Clark
Journal:  Bone Marrow Transplant       Date:  2014-02-17       Impact factor: 5.483

3.  NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome.

Authors:  Neema P Mayor; Bronwen E Shaw; J Alejandro Madrigal; Steven G E Marsh
Journal:  Bone Marrow Res       Date:  2012-10-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.